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Occupational carcinogens occupy a special
place among the different classes of human
carcinogens. The occupational environment
has been a most fruitful one for investigating
the etiology and pathogenesis of human can-
cer. Up to the 1970s, most recognized human
carcinogens were substances or circumstances
found primarily in the occupational environ-
ment, and although this may no longer be
true with the growing list of recognized non-
occupational carcinogens, they still represent
a large fraction of the total. Although it is
important to discover occupational carcino-
gens for the sake of preventing occupational
cancer, the potential beneﬁt of such discover-
ies goes beyond the factory walls because
most occupational exposures find their way
into the general environment, sometimes at
higher concentrations than in the workplace.
There is a large volume of epidemiologic
and experimental data concerning cancer risks
in different work environments. It is impor-
tant to synthesize this information for both
scientiﬁc and public health purposes. Various
national and international bodies have pub-
lished lists of carcinogens, but available lists of
occupational carcinogens have been limited in
various ways. Among the issues that are often
missing, or treated rather casually, are a
coherent assessment of which substances
should be considered occupational carcino-
gens; information on the occupations and
industries in which the carcinogenic sub-
stances may be found; and the target sites of
cancer. The present article represents an
attempt to summarize, in tabular form, current
knowledge on occupational carcinogens, the
occupations and industries in which they are
found, and their target organs.
Methods and Results
Difficulties in listing occupational carcino-
gens. Although it seems like a simple enough
task, it is very difﬁcult to draw up an unam-
biguous list of occupational carcinogens. The
ﬁrst source of ambiguity concerns the deﬁni-
tion of an “occupational” carcinogen. Most
occupational exposures are also found in the
general environment, and/or in consumer
products; most general environmental expo-
sures and consumer products, including medi-
cations, foods, and others, are found in some
occupational environments. The distinctions
can be quite arbitrary. For instance, although
tobacco smoke, sunlight, and immuno-
suppressive medications are not primarily con-
sidered to be occupational exposures, there
certainly are workers whose occupations bring
them into contact with these agents. Also,
although asbestos, benzene, and radon gas are
considered to be occupational carcinogens,
they are also found widely among the general
population, and indeed, it is likely that many
more people are exposed to these substances
outside than inside the occupational environ-
ment. There is no simple rule to earmark
occupational carcinogens as opposed to
nonoccupational ones. Further, some carcino-
gens are chemicals that are used for research
purposes and to which few people would ever
be exposed, whether occupationally or non-
occupationally. Our operational criterion for
designating occupational carcinogens is out-
lined below.
A second source of ambiguity derives
from the rather idiosyncratic nature of the
evidence. In some instances, we know that an
occupational or industrial group is at excess
risk of cancer, and we have a good idea of the
causative agent; for example, scrotal cancer
among chimney sweeps and polyaromatic
hydrocarbons (PAHs) in soot (Waldron
1983), and lung cancer among asbestos min-
ers and asbestos ﬁbers [International Agency
for Research on Cancer (IARC) 1977]. In
some instances, we know that a group experi-
enced excess risk but the causative agent is
unknown or at least unproven [e.g., lung can-
cer among painters (IARC 1989c), bladder
cancer among workers in the aluminum
industry (IARC 1987)]. The strength of the
evidence for an association can vary. For some
associations, the evidence of excess risk seems
incontrovertible [e.g., liver angiosarcoma and
vinyl chloride monomer (IARC 1979b), blad-
der cancer and benzidine (IARC 1982b)]. For
some associations, the evidence is suggestive
[e.g., lung cancer and diesel engine exhaust
(IARC 1989a), bladder cancer and employ-
ment as a painter (IARC 1989c)]. Among the
many substances in the industrial environ-
ment for which there are no human data con-
cerning carcinogenicity, there are hundreds
that have been shown to be carcinogenic in
some animal species and thousands that have
been shown to have some effect in assays of
mutagenicity or genotoxicity. These con-
siderations complicate the attempt to devise a
list of occupational carcinogens.
IARC Monographs. For this task we
drew on the authoritative IARC Monograph
Program and its evaluation of carcinogenic
risks to humans (IARC 1987). The objective
of the IARC Monograph Program, which has
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The occupational environment has been a most fruitful one for investigating the etiology of
human cancer. Many recognized human carcinogens are occupational carcinogens. There is a large
volume of epidemiologic and experimental data concerning cancer risks in different work environ-
ments. It is important to synthesize this information for both scientific and public health pur-
poses. Various organizations and individuals have published lists of occupational carcinogens.
However, such lists have been limited by unclear criteria for which recognized carcinogens should
be considered occupational carcinogens, and by inconsistent and incomplete information on the
occupations and industries in which the carcinogenic substances may be found and on their target
sites of cancer. Based largely on the evaluations published by the International Agency for
Research on Cancer, and augmented with additional information, the present article represents an
attempt to summarize, in tabular form, current knowledge on occupational carcinogens, the occu-
pations and industries in which they are found, and their target organs. We have considered
28 agents as definite occupational carcinogens, 27 agents as probable occupational carcinogens,
and 113 agents as possible occupational carcinogens. These tables should be useful for regulatory
or preventive purposes and for scientiﬁc purposes in research priority setting and in understanding
carcinogenesis. Key words: cancer, environment, epidemiology, occupation, review. Environ
Health Perspect 112:1447–1459 (2004). doi:10.1289/ehp.7047 available via http://dx.doi.org/
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Research Reviewbeen operating since 1971, is to publish criti-
cal reviews of epidemiologic and experimental
data on carcinogenicity for chemicals, groups
of chemicals, industrial processes, other com-
plex mixtures, physical agents, and biologic
agents to which humans are known to be
exposed, to evaluate the data in terms of
human risk, and to indicate where additional
research efforts are needed.
Substances are selected by IARC for
evaluation on the basis of two main criteria:
a) humans are exposed, and b) there is reason
to suspect that the substance may be carcino-
genic. Direct evidence concerning carcino-
genicity of a substance can come from
epidemiologic studies among humans or from
experimental studies of animals (usually
rodents). Additional evidence comes from the
results of studies of chemical structure–activity
analysis, absorption and metabolism, physiol-
ogy, mutagenicity, cytotoxicology, and other
aspects of toxicity. In the IARC Monographs,
all types of data contribute to the evaluation.
In this article, we outline the IARC
process because it is important to understand
how decisions are made in order to properly
interpret these decisions. IARC evaluations are
carried out during specially convened meet-
ings that typically last a week. The meetings
may evaluate only one agent, such as silica, or
they may address a set of related agents or
even exposure circumstances such as an occu-
pation or an industry. For each such meeting,
and there have typically been three per year,
IARC convenes an international working
group, usually involving from 15 to 30 experts
on the topic(s) being evaluated, from four per-
spectives, a) exposure and occurrence of the
substances being evaluated, b) human evi-
dence of cancer risk (i.e., epidemiology),
c) animal carcinogenesis, and d) other data
relevant to the evaluation of carcinogenicity
and its mechanisms. The working group is
asked to review all of the literature relevant to
an assessment of carcinogenicity. In the first
part of the meeting, four subgroups (based on
the four perspectives mentioned above) review
and revise drafts prepared by members of the
subgroup, and each subgroup develops a joint
review and evaluation of the evidence on
which they have focused. Subsequently, the
entire working group convenes in plenary and
proceeds to derive a joint text. They determine
whether the epidemiologic evidence supports
the hypothesis that the substance causes can-
cer, and, separately, whether the animal evi-
dence supports the hypothesis that the
substance causes cancer. The judgments are
not simply dichotomous (yes/no), but rather
they allow the working group to express a
range of opinions on each of the dimensions
evaluated. Table 1 shows the categories into
which the working groups are asked to classify
each substance, when examining only the epi-
demiologic evidence and when examining
only the animal experimental evidence. The
operational criteria for making these decisions
leave room for interpretation, and the scien-
tiﬁc evidence itself is open to interpretation. It
is not surprising, then, that the evaluations are
sometimes difﬁcult and contentious.
The overall evaluation of human carcino-
genicity is based on the epidemiologic and
animal evidence of carcinogenicity, plus any
other relevant evidence on genotoxicity,
mutagenicity, metabolism, or mechanisms.
Epidemiologic evidence, where it exists, is
given greatest weight. Direct animal evidence
of carcinogenicity is next in importance, with
increasing attention paid to mechanistic 
evidence that can inform the relevance of the
animal evidence for human risk assessment.
Table 2 shows the categories for the overall
evaluation and how they are derived from
human, animal, and other evidence. Each sub-
stance is classified into one of the following
groups: carcinogenic (group 1), probably car-
cinogenic (group 2A), possibly carcinogenic
(group 2B), not classiﬁable (group 3), proba-
bly not carcinogenic (group 4). However, the
algorithm implied by Table 2 is only indica-
tive, and the working group may derive an
overall evaluation that departs from the strict
interpretation of the algorithm. For example,
neutrons have been classified as human car-
cinogens (group 1) despite the absence of epi-
demiologic data, because of overwhelming
experimental evidence and mechanistic con-
siderations (IARC 2000a). The IARC process
relies on consensus, and this is usually
achieved, but sometimes differing opinions
among experts lead to split decisions. In the
end, the published evaluations reflect the
views of at least a majority of participating
experts. The results of IARC evaluations are
published in readily available and user-friendly
volumes, and summaries are published on the
IARC website (IARC 2003).
For our purpose, there are several limita-
tions to bear in mind. First, IARC does not
provide any explicit indication as to whether
the substance evaluated should be considered
an occupational exposure. Second, although
the working groups certainly study the evi-
dence in relation to cancer sites, until recently
the formal evaluations did not identify which
sites of cancer may be at risk. Site-specific
information needs to be gleaned from the
working group’s report and other literature.
Third, the evaluations are anchored in the
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Table 1. Classiﬁcations used in the IARC Monographs to characterize evidence of carcinogenicity.
Category of evidence In humans In animals
Sufﬁcient evidence of A causal relationship has been established between exposure to A causal relationship has been established between the agent or
carcinogenicity the agent, mixture, or exposure circumstances and human cancer. mixture and an increased incidence of malignant neoplasms or of 
That is, a positive relationship has been observed between the an appropriate combination of benign and malignant neoplasms in 
exposure and cancer in studies in which chance, bias, and a) two or more species of animals or b) in two or more independent 
confounding could be ruled out with reasonable conﬁdence. studies in one species carried out at different times or in different 
laboratories or under different protocols.
Limited evidence of A positive association has been observed between exposure to the The data suggest a carcinogenic effect but are limited for making a 
carcinogenicity agent, mixture, or exposure circumstance and cancer for which deﬁnitive evaluation because, for example, a) the evidence of 
a causal interpretation is considered to be credible, but chance, bias,  carcinogenicity is restricted to a single experiment; b) there are 
or confounding could not be ruled out with reasonable conﬁdence. unresolved questions regarding the adequacy of the design, conduct, 
or interpretation of the study; or c) the agent or mixture increases 
the incidence only of benign neoplasms or lesions of uncertain 
neoplastic potential, or of certain neoplasms that may occur 
spontaneously in high incidences in certain strains.
Insufﬁcient evidence of The available studies are of insufﬁcient quality, consistency, or  The studies cannot be interpreted showing either the presence or 
carcinogenicity statistical power to permit a conclusion regarding the presence absence of a carcinogenic effect because of major qualitative or
or absence of a causal association between exposure and cancer,  quantitative limitations, or no data on cancer in experimental 
or no data on cancer in humans are available. animals are available.
Evidence suggesting There are several adequate studies covering the full range of levels  Adequate studies involving at least two species are available which 
lack of carcinogenicity of exposure that human beings are known to encounter, which are show that, within the limits of the tests used, the agent or mixture is 
mutually consistent in not showing a positive association between not carcinogenic.
exposure to the agent, mixture, or exposure circumstance and any
studied cancer at any observed level of exposure.time that the working group met and reviewed
the evidence; it is possible that evidence
appearing after the IARC review could change
the evaluation.
Current knowledge on occupational car-
cinogens. From 1972 through 2003, the IARC
Monograph Program published 83 volumes,
representing evaluations of more than
880 substances, complex mixtures, and indus-
trial processes. Of these, 89 have been classed
as deﬁnite human carcinogens, 64 as probable,
and 264 as possible human carcinogens
(IARC 2003). We reviewed each one and ear-
marked those that we consider to be “occupa-
tional exposures.”
In developing a decision rule, we consid-
ered the following dimensions: whether the
evidence of an effect drew on studies in
exposed workers, whether the agent was
found more often in the occupational or non-
occupational environments, and the numbers
of workers exposed. In the end, the ﬁrst two
dimensions became redundant when we
applied the third. Thus, a substance was con-
sidered an occupational exposure if there are,
or have been, signiﬁcant numbers of workers
exposed to the substance at signiﬁcant levels.
The fact that some workers were exposed to a
substance was not enough to label it as an
occupational carcinogen. There are many car-
cinogens to which few workers are exposed,
and we did not want to dilute the lists with
such obscure agents.
Unfortunately, the knowledge base for
determining how many workers are or have
been exposed, and at what levels, is very frag-
mentary. We relied on available documenta-
tion such as the IARC Monographs, surveys by
the National Institute for Occupational Safety
and Health (NIOSH 1990), the National
Toxicology Program (NTP) Report on
Carcinogens, Tenth Edition (NTP 2002), and
informed guesses on the part of expert indus-
trial hygienists. Where we could come up with
approximate numbers of workers exposed, we
had to have some type of operational thresh-
old for what should be considered a signiﬁcant
number. As a rule of thumb, we used
> 10,000 workers exposed worldwide or
> 1,000 in any country, presently or at any
time in the past. These were the guidelines
against which we measured our imprecise and
semisubjective estimates. We also had to oper-
ationalize the notion of a level of exposure that
was signiﬁcant. This was even less explicit than
the criteria used for numbers of workers
exposed; it depended, inter alia, on the known
range of exposure levels to the agent.
Despite the fact that they may be found
in occupational environments, some classes of
agents were summarily excluded from consid-
eration on the grounds that the exposures are
rare or very infrequent or at very low doses.
These included hormones, pharmaceuticals,
microbiologic agents, and dietary con-
stituents. Pharmaceuticals represent a special
case. Many have been evaluated, and many
are considered to be carcinogenic. Although
the main population exposed consists of
patients undergoing therapy, there can also be
exposure of workers who produce the drugs
and of health care workers who administer
them. But because the exposure doses are
orders of magnitude higher among patients
than among workers, we have not listed these
as occupational carcinogens. Analogously, we
have not listed carcinogenic viruses, notably,
human immunodeficiency virus (HIV) and
hepatitis B and C viruses, although health
care workers may be at risk.
With these criteria, we derived the follow-
ing lists of occupational carcinogens:
• 28 deﬁnite human occupational carcinogens
(IARC group 1; Table 3)
• 27 probable human occupational carcino-
gens (IARC group 2A; Table 4)
• 113 possible human occupational carcino-
gens (IARC group 2B; Table 5)
• 18 occupations and industries that possibly,
probably, or definitely entail excess risk of
cancer (IARC groups 1, 2A, and 2B;
Table 6).
Tables 3–6 only include agents and cir-
cumstances that were reviewed and published
by the IARC Monograph Program as of 2003.
As discussed above, the evaluations are rooted
in the information base that was available at
the time of the IARC evaluation. As evidence
accumulates, the evaluation of an agent can
change, as has already occurred in some cases
(e.g., cadmium, acrylonitrile). This is why we
have included in the tables a reference to the
IARC volume in which the substance was
evaluated and its date. Evaluations with early
dates are more vulnerable to being out of date.
In a special review published in 1987
(Supplement 7), all substances and occupa-
tions covered in the ﬁrst 15 years of the pro-
gram were reevaluated (IARC 1987). Thus,
every substance for which the Supplement 7
reference is cited had an earlier monograph.
For many of the substances, there was little, if
any, new information, and consequently, we
have quoted the original monograph for those
without any new data in 1987. For those sub-
stances referenced as Supplement 7, new data
were available for the reevaluation.
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Table 2. Guidelines used by the IARC Monographs Program in evaluating human carcinogenicity based on the synthesis of epidemiologic, animal, and other
evidence.a
Combinations that ﬁt in this group
Group Description of group Epidemiologic evidence Animal evidence Other evidence
1 The agent, mixture, or exposure circumstance is carcinogenic to humans Sufﬁcient Any Any
Less than sufﬁcient Sufﬁcient Strongly positive
2A The agent, mixture, or exposure circumstance is probably carcinogenic to humans Limited Sufﬁcient Less than
strongly positive
Inadequate or not Sufﬁcient Strongly positive
available
2B The agent, mixture, or exposure circumstance is possibly carcinogenic to humans Limited Less than sufﬁcient Any
Inadequate or not Sufﬁcient Less than
available strongly positive
Inadequate or not Limited Strongly positive
available
3 The agent, mixture, or exposure circumstance is not classiﬁable as to its  Inadequate or not Limited Less than
carcinogenicity to humans available strongly positive
Not elsewhere classiﬁed
4 The agent, mixture, or exposure circumstance is probably not carcinogenic  Suggesting lack of Suggesting lack of Any
to humans carcinogenicity carcinogenicity
Inadequate or not Suggesting lack of Strongly
available carcinogenicity negative
aThis table shows our interpretation of the IARC Monographs Program guidelines to derive the overall evaluation from the combined epidemiologic, animal, and other evidence.
However, the IARC working groups can, under exceptional circumstances, depart from these guidelines in deriving the overall evaluation (IARC 2003). For example, the overall evalua-
tion can be downgraded if there is less than sufﬁcient evidence in humans and strong evidence that the mechanism operating in animals is not relevant to humans.For the agents in Tables 3–5, we devised a
set of subheadings to help the reader digest the
long lists of often obscure chemical names:
physical agents, respirable dusts and fibers,
metals and metal compounds, PAHs, wood
and fossil fuels and their by-products,
monomers, intermediates in plastics and rub-
ber manufacturing, chlorinated hydrocarbons,
aromatic amine dyes, azo dyes, intermediates
in the production of dyes, pesticides, nitro
compounds, and others. Tables 3–5 indicate
some of the main occupations or industries in
which each listed substance is found, and the
strength of evidence from human and animal
studies. In Tables 3 and 4, we show the type(s)
of cancer affected, with an indication of the
strength of evidence for each type listed.
Information on target organ is not shown in
Table 5 because, for agents listed as possible
carcinogens, evidence concerning humans is
either conﬂicting or not available at all.
For many of the agents listed, but not all,
there has been some epidemiologic evidence of
carcinogenicity among exposed workers. For
most of the agents listed, but not all, the occu-
pational environment represents the most
common locale of exposure. The most promi-
nent exceptions to this rule are aﬂatoxins, sun-
light, involuntary tobacco smoking, and radon.
Whether these cause more cases of cancer as a
result of occupational or nonoccupational
exposure depends on numbers exposed and
exposure levels in the two types of milieu. It is
plausible that there may be more cases result-
ing from nonoccupational exposure.
The IARC Monograph Program has occa-
sionally addressed cancer risk in various occu-
pations and industries, as well as agents.
However, although the monograph program
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Table 3. Substances and mixtures that have been evaluated by IARC as deﬁnite (group 1) human carcinogens and that are occupational exposures.
IARC Monograph Human Animal
Substance or mixture Occupation or industry in which the substance is founda volume (year)b evidencec evidencec Site(s)
Physical agents
Ionizing radiation and sources Radiologists; technologists; nuclear workers; radium-dial  Vol. 75 (2000a) Sufﬁcient Sufﬁcient Boned
thereof, including, notably, painters; underground miners; plutonium workers; cleanup  Vol. 78 (2001a) Leukemiad
X rays, γ rays, neutrons, and  workers following nuclear accidents; aircraft crew Lungd
radon gas Liverd
Thyroidd
Othersd
Solar radiation Outdoor workers Vol. 55 (1992b) Sufﬁcient Sufﬁcient Melanomad
Skind
Respirable dusts and ﬁbers
Asbestos Mining and milling; by-product manufacture; insulating; Suppl. 7 (1987) Sufﬁcient Sufﬁcient Lungd
shipyard workers; sheet-metal workers; asbestos  Mesotheliomad
cement industry Larynxe 
GI tracte
Erionite Waste treatment; sewage; agricultural waste; air pollution  Suppl. 7 (1987) Sufﬁcient Sufﬁcient Mesotheliomad
control systems; cement aggregates; building materials
Silica, crystalline Granite and stone industries; ceramics, glass, and Vol. 68 (1997b) Sufﬁcient Sufﬁcient Lungd
related industries; foundries and metallurgical industries;
abrasives; construction; farming
Talc containing  Manufacture of pottery, paper, paint, and cosmetics Suppl. 7 (1987) Sufﬁcient Inadequate Lungd
asbestiform ﬁbers Mesotheliomad
Wood dust Logging and sawmill workers; pulp and paper and  Vol. 62 (1995b) Sufﬁcient Inadequate Nasal cavities 
paperboard industry; woodworking trades (e.g., furniture  and paranasal 
industries, cabinetmaking, carpentry and construction);  sinusesd
used as ﬁller in plastic and linoleum production
Metals and metal compounds
Arsenic and arsenic  Nonferrous metal smelting; production, packaging, and  Suppl. 7 (1987) Sufﬁcient Limited Skind
compounds use of arsenic-containing pesticides; sheep dip  Lungd
manufacture; wool ﬁber production; mining of ores  Liver 
containing arsenic (angiosarcoma)e
Beryllium Beryllium extraction and processing; aircraft and aerospace  Vol. 58 (1993a) Sufﬁcient Sufﬁcient Lungd
industries; electronics and nuclear industries; jewelers
Cadmium and cadmium  Cadmium-smelter workers; battery production workers; Vol. 58 (1993a) Sufﬁcient Sufﬁcient Lungd
compounds cadmium-copper alloy workers; dyes and pigments 
production; electroplating processes
Chromium compounds,  Chromate production plants; dyes and pigments; plating  Vol. 49 (1990a) Sufﬁcient Sufﬁcient Lungd
hexavalent  and engraving; chromium ferro-alloy production;  Nasal sinusese
stainless-steel welding; in wood preservatives; leather
tanning; water treatment; inks; photography; lithography;
drilling muds; synthetic perfumes; pyrotechnics;
corrosion resistance
Selected nickel compounds, Nickel reﬁning and smelting; welding Vol. 49 (1990a) Sufﬁcient Sufﬁcient Lungd
including combinations of  Nasal cavity
nickel oxides and sulﬁdes  and sinusesd
in the nickel reﬁning industry
Wood and fossil fuels and their by-products
Benzene Production; solvents in the shoe production industry; chemical, Suppl. 7 (1987) Sufﬁcient Limited Leukemiad
pharmaceutical, and rubber industries; printing industry 
(rotogravure plants, bindery departments); gasoline additive
Coal tars and pitches Production of reﬁned chemicals and coal tar products  Suppl. 7 (1987) Sufﬁcient Sufﬁcient Skind
(patent-fuel); coke production; coal gasiﬁcation; aluminum  Lunge
production; foundries; road paving and construction (roofers  Bladdere
and slaters)
Continued next pageaims at a systematic evaluation of agents and
complex mixtures, it is not intended to pro-
vide a systematic review of cancer risk by
industries and occupations. That is, those
reviews were conducted where there were par-
ticular concerns or anticipated insights
regarding specific potential carcinogens.
Sometimes this was done when there
appeared to be strong evidence of risk in an
occupation but little indication of what the
responsible agent might be (e.g., rubber
industry, painters). Sometimes the impetus
for an occupation or industry review came
from the attempt to evaluate some agent, but
it was realized that the evidence regarding
that agent was rooted in epidemiologic evi-
dence regarding some occupation or industry
(e.g., glass industry, hairdresser). Table 6
shows those occupations and industries that
IARC has evaluated as deﬁnitely, probably, or
possibly entailing a carcinogenic risk. Because
there has been no pretense of exhaustiveness
in evaluating occupations and industries, the
absence of an occupation or industry in
Table 6 does not carry the same signiﬁcance
as the absence of an agent in Tables 3–5.
That is, it does not signify that there is no
known risk for that occupation or industry.
Because our inclusion criteria admitted
substances to which workers were exposed in
the past, we included some substances that
have been banned or virtually eliminated in
some countries, such as mustard gas,
bis(chloromethyl) ether, tris(2,3-dibromo-
propyl) phosphate, and 4,4´-methylene bis(2-
chloroaniline) (MOCA), as well as some
industries that no longer exist (viz., production
of auramine and magenta). These are men-
tioned partly for historic interest and partly
because it is possible that these might yet be
used in some places at some time.
It is important to note that the sub-
stances, occupations, and industries listed in
Tables 3–6 are not mutually exclusive.
Certainly, some of the occupations and indus-
tries listed in Table 6 may be there because of
some of the substances that are listed in
Tables 3–5. But further, the substances relate
to each other in complicated ways. Some fami-
lies of substances include some specific sub-
stances that are also listed (e.g., nonarsenical
insecticides, which includes DDT; benzidine-
based dyes, which includes benzidine). Also,
there are some complex mixtures (e.g., diesel
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Mineral oils, untreated  Production; used as lubricant by metal workers, machinists,  Suppl. 7 (1987) Sufﬁcient Inadequate Skind
and mildly treated engineers; printing industry (ink formulation); used in  Bladdere
cosmetics, medicinal and pharmaceutical preparations Lunge
Nasal sinusese
Shale oils or shale-derived  Mining and processing; used as fuels or chemical-plant  Suppl. 7 (1987) Sufﬁcient Sufﬁcient Skind
lubricants feedstocks; lubricant in cotton textile industry
Soots Chimney sweeps; heating-unit service personnel; brick  Vol. 35 (1985) Sufﬁcient Inadequate Skind
masons and helpers; building demolition workers; insulators; Lungd
ﬁreﬁghters; metallurgical workers; work involving burning Esophaguse
of organic materials
Monomers
Vinyl chloride Production; production of polyvinyl chloride and co-polymers; Suppl. 7 (1987) Sufﬁcient Sufﬁcient Liver
refrigerant before 1974; extraction solvent; in aerosol  (angiosarcoma)d
propellants Liver
(hepato-
cellular)e
Intermediates in plastics and rubber manufacturing
Bis(chloromethyl) ether and  Production; chemical intermediate; alkylating agent;  Suppl. 7 (1987) Sufﬁcient Sufﬁcient Lung (oat cell)d
chloromethyl methyl ether  laboratory reagent; plastic manufacturing; ion-exchange 
(technical grade)  resins and polymers
Aromatic amine dyes
4-Aminobiphenyl Production; dyestuffs and pigment manufacture Suppl. 7 (1987) Sufﬁcient Sufﬁcient Bladderd
Benzidine Production; dyestuffs and pigment manufacture Suppl. 7 (1987) Sufﬁcient Sufﬁcient Bladderd
2-Naphthylamine Production; dyestuffs and pigment manufacture Suppl. 7 (1987) Sufﬁcient Sufﬁcient Bladderd
Pesticides
Ethylene oxide Production; chemical industry; sterilizing agent  Vol. 60 (1994) Limited Sufﬁcient Leukemiad
(hospitals, spice fumigation)
2,3,7,8-Tetrachlorodibenzo- Production; use of chlorophenols and chlorophenoxy  Vol. 69 (1997a) Limited Sufﬁcient All sites 
para-dioxin (TCDD) herbicides; waste incineration; PCB production;  combinedd
pulp and paper bleaching  Lunge
Non-Hodgkin
lymphomae
Sarcomae
Others
Aﬂatoxin Feed production industry; workers loading and unloading  Vol. 82 (2002b) Sufﬁcient Sufﬁcient Liverd
cargo; rice and maize processing
Involuntary (passive) smoking  Workers in bars and restaurants; ofﬁce workers Vol. 83 (2004) Sufﬁcient Sufﬁcient Lungd
Mustard gas Production; used in research laboratories; military personnel  Suppl. 7 (1987) Sufﬁcient Limited Larynxd
Lunge
Pharynxe
Strong inorganic-acid mists  Pickling operations; steel industry; petrochemical industry; Vol. 54 (1992a) Sufﬁcient Not available Larynxd
containing sulfuric acid phosphate acid fertilizer manufacturing  Lunge
aNot necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term “production” is used to
indicate that this substance is man-made and that workers may be exposed in the production process. bMost recent IARC evaluation; for those referenced to Supplement 7 (IARC 1987),
it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated at an earlier date. cAs judged by the IARC working group; we added the notation
“not available” to signify those substances for which there was no evidence at all. dWe judged that evidence for an association with this site was strong. eWe judged that evidence was
suggestive.
Table 3. Continued
IARC Monograph Human Animal
Substance or mixture Occupation or industry in which the substance is founda volume (year)b evidencec evidencec Site(s)exhaust) that contain a substance on the list
(e.g., nitro-PAHs) that may be responsible for
the carcinogenicity of the mixture.
The listing of affected cancer sites in
Tables 3 and 4 does not come explicitly from
the IARC Monographs. Sometimes the
affected target organ(s) was rather evident,
but sometimes it required that we evaluate
the evidence, including evidence published
more recently than the IARC evaluation in
question. Table 7 shows the same agents
listed in Tables 3 and 4 but organized by site
of cancer. Again, we indicate clearly which
associations are strong and which are only
suggestive. The lung is the target organ that
has most often been linked to occupational
carcinogens.
The evolution of knowledge. In order to
appreciate how knowledge has evolved, we
searched for information on the current
occupational carcinogens at two earlier time
periods. As mentioned above, IARC carried
out a comprehensive cumulative synthesis in
1987 (IARC 1987). In that report, the results
were presented with the same rating system
(group 1, 2A, 2B, 3) as is used today, render-
ing the lists comparable. In 1964, even
before the establishment of IARC, the
World Health Organization (WHO) com-
missioned an expert panel to survey available
knowledge on human carcinogens (WHO
1964). In the WHO report, there was no
explicit rating system. It was a discursive pre-
sentation of knowledge and opinions that we
attempted, with some license, to translate
into a simple system corresponding to defi-
nite, probable/possible, or not mentioned.
From these two reports, we searched for ref-
erences to the 168 substances presented in
Tables 3–5 and that are currently considered
to be definite, probable, or possible occupa-
tional carcinogens.
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Table 4. Substances and mixtures that have been evaluated by IARC as probable (group 2A) human carcinogens and that are occupational exposures.
IARC Monograph Human Animal
Substance or mixture Occupation or industry in which the substance is founda volume (year)b evidencec evidencec Site(s)
Physical agents
Ultraviolet radiation  Arc welding; industrial photoprocesses; sterilization  Vol. 55 (1992b)  Inadequate Sufﬁcient Melanomad
(A, B, and C) from  and disinfection; phototherapy; operating theaters; 
artiﬁcial sources research laboratories; ultraviolet ﬂuorescence in 
food industry; insect traps
Polyaromatic hydrocarbons
Benz[a]anthracene Work involving combustion of organic matter; foundries;  Vol. 32 (1983b) Not available Sufﬁcient Lungd
steel mills; ﬁreﬁghters; vehicle mechanics  Bladderd
Skind
Benzo[a]pyrene Work involving combustion of organic matter; foundries;  Vol. 32 (1983b) Not available Sufﬁcient Lungd
steel mills; ﬁreﬁghters; vehicle mechanics Bladderd
Skind
Dibenz[a,h]anthracene Work involving combustion of organic matter; foundries;  Vol. 32 (1983b) Not available Sufﬁcient Lungd
steel mills; ﬁreﬁghters; vehicle mechanics Bladderd
Skind
Wood and fossil fuels and their by-products
Creosotes Brickmaking; wood preserving Vol. 35 (1985) Limited Sufﬁcient Skind
Diesel engine exhaust Railroad workers; professional drivers; dock workers;  Vol. 46 (1989a) Limited Sufﬁcient Lungd
mechanics  Bladderd
Intermediates in plastics and rubber manufacturing
4,4´-Methylene bis(2-chloroaniline) Production; curing agent for rooﬁng and wood sealing Vol. 57 (1993b) Inadequate Sufﬁcient Bladderd
Styrene-7,8-oxide Production; styrene glycol production; perfume  Vol. 60 (1994) Inadequate Sufﬁcient
preparation; reactive diluent in epoxy resin formulations; 
as chemical intermediate for cosmetics, surface coating, 
and agricultural and biological chemicals; used for 
treatment of ﬁbers and textiles; in fabricated rubber 
products
Chlorinated hydrocarbons
α-Chlorinated toluenes Production; dye and pesticide manufacture Vol. 71 (1999a) Limited Sufﬁcient Lungd
Polychlorinated biphenyls Production; electrical capacitor manufacturing  Suppl. 7 (1987) Limited Sufﬁcient Liver and biliary
tractd
Tetrachloroethylene Production; dry cleaning; metal degreasing Vol. 63 (1995a) Limited Sufﬁcient Cervixd
Esophagusd
Non-Hodgkin
lymphomad
Trichloroethylene Production; dry cleaning; metal degreasing  Vol. 63 (1995a) Limited Sufﬁcient Liver and 
biliary tractd
Non-Hodgkin
lymphomad
Renal celld
Monomers
Acrylamide Chemical industry; water and wastewater treatment;  Vol. 60 (1994) Inadequate Sufﬁcient Pancreasd
textile, steel, and lumber industries; petroleum 
reﬁning; mineral processing; sugar production; hospitals
1,3-Butadiene Chemical and rubber industries Vol. 71 (1999a) Limited Sufﬁcient Lympho-
hematopoieticd
Epichlorohydrin Production and use of resins, glycerine, and propylene- Vol. 71 (1999a) Inadequate Sufﬁcient Lungd
based rubbers; used as a solvent CNSd
Vinyl bromide Production; production of vinyl bromide polymers  Vol. 71 (1999a) Not available Sufﬁcient
and monoacrylic ﬁbers for carpet backing material; 
rubber and plastic production
Vinyl ﬂuoride Production; polyvinyl ﬂuoride and ﬂuoropolymer production Vol. 63 (1995a) Not available Sufﬁcient
Continued next pageTable 8 shows how the current occupa-
tional carcinogens were considered in two ear-
lier times. Half of today’s recognized deﬁnite
occupational carcinogens were already recog-
nized as such by 1964, in the early period of
cancer epidemiology. Nearly 90% were con-
sidered to be definite or probable as of
15 years ago. In contrast, > 95% of today’s
probable and possible occupational carcino-
gens had not even been mentioned as of 1964,
and about one-third were not mentioned as of
1987. Although it is possible for the classiﬁca-
tion of agents to change over time in either
direction, in practice there have been rather
few instances of agents being “downgraded”
between successive periods. Notable counter-
examples include the following:
• 3,3-Dichlorobenzene, which was considered
a deﬁnite carcinogen in 1964 but was only
considered as a possible carcinogen as of
1987 and 2002
• Acrylonitrile and propylene oxide, which were
considered probable carcinogens in 1987,
but only as possible carcinogens in 2002
• Glass wool was considered a possible carcino-
gen in 1988 but was downgraded to unclassi-
ﬁable in 2002
• Ionizing radiation, a special case, was con-
sidered a deﬁnite carcinogen in 1964 and is
so considered today, but it had not been
reviewed by IARC before the 1990s; there-
fore, we had to classify it as “unrated” in
1987.
Discussion
Many of the recognized deﬁnite occupational
carcinogens were ﬁrst suspected before the era
of modern epidemiology (i.e., before 1950).
The signiﬁcance of this observation is unclear.
It may be that there were only a limited num-
ber of strong occupation–cancer associations,
and these were sufﬁciently obvious that they
could produce observable clusters of cases for
astute clinicians to notice. It may be that levels
of exposure to occupational chemicals were so
high before the 1950s as to produce high can-
cer risks and cancer clusters, but that improve-
ments in industrial hygiene in industrialized
countries have indeed decreased risks to levels
that are difficult to detect. The number of
occupational agents rated by IARC as group 1
carcinogens has tapered off since 1987,
whereas the proportion of group 2B evalua-
tions has increased. This reﬂects the fact that,
when the monograph program began, there
was a “backlog” of agents for which strong evi-
dence of carcinogenicity had accumulated,
and, naturally, these were the agents that
IARC initially selected for review. Once the
agents with strong evidence had been dealt
with, IARC started dealing with others. It
would be wrong to infer that the historic trend
in IARC designations signals that we are
approaching the end of the period of potential
to discover occupational carcinogens. There
are many thousands of chemicals in work-
places, and new ones are continuously being
introduced. Most recognized occupational
carcinogens were first suspected on the basis
of case reports by clinicians or pathologists
(Doll 1975). These discoveries were usually
coincidental (Siemiatycki et al. 1981). It is
thus reasonable to suspect that there may be
some, perhaps many, as yet undiscovered
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Aromatic amine dyes
Benzidine-based dyes Production; used in textile, paper,  Suppl. 7 (1987) Inadequate Sufﬁcient Bladderd
leather, rubber, plastics, printing, 
paint, and lacquer industries
4-Chloro-ortho-toluidine Dye and pigment manufacture;  Vol. 77 (2000b) Limited Sufﬁcient Bladderd
textile industry
ortho-Toluidine Production; manufacture of dyestuffs,  Vol. 77 (2000b) Limited Sufﬁcient Bladderd
pigments, optical brightener, 
pharmaceuticals, and pesticides; 
rubber vulcanizing; clinical laboratory 
reagent; cleaners and janitors
Intermediates in the production of dyes
Dimethylcarbamoyl chloride Production; manufacture of pharmaceuticals,  Vol. 71 (1999a) Inadequate Sufﬁcient
pesticides, and dyes
Pesticides
Captafol Production; fungicide Vol. 53 (1991b) Not available Sufﬁcient
Ethylene dibromide Production; pest control; petroleum reﬁning and  Vol. 71 (1999a) Inadequate Sufﬁcient
waterprooﬁng; leaded gasoline additive; chemical 
intermediate and solvent in gums, waxes, resins, dyes,
and pharmaceutical preparations
Nonarsenical insecticides Production; pest control and agricultural  Vol. 53 (1991b) Limited Not available Braind
workers; ﬂour and grain mill workers  Leukemiad
Lungd
Multiple
myelomad
Non-Hodgkin
lymphomad
Others
Diethyl sulfate Ethanol production Vol. 71 (1999a) Not available Sufﬁcient
Formaldehyde Production; pathologists; medical laboratory technicians;  Vol. 62 (1995b) Limited Sufﬁcient Leukemiad
plastics; textile industry  Nasal sinusesd
Nasopharynxd
Tris(2,3-dibromopropyl)  Production; used in the textile phosphate industry;  Vol. 71 (1999a) Inadequate Sufﬁcient
in phenolic resins (for electronics industry), paints, 
paper coatings, and rubber
CNS, central nervous system.
aNot necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term “production” is used to
indicate that this substance is man-made and that workers may be exposed in the production process. bMost recent IARC evaluation; for those referenced as Supplement 7 (IARC 1987),
it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated at an earlier date. cAs judged by the IARC working group; we added the notation
“not available” to signify those substances for which there was no epidemiologic evidence at all. dWe judged that the evidence was suggestive.
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Table 5. Substances and mixtures that have been evaluated by IARC as possible (group 2B) human carcinogens and that are occupational exposures.
IARC Monograph  Human Animal
Substance or mixture Occupation or industry in which the substance is founda volume (year)b evidencec evidencec
Respirable dusts and ﬁbers
Glass wool Production; construction and insulation  Vol. 81 (2002a) Inadequate Sufﬁcient
Palygorskite (long ﬁbers > 5 µm) Miners and millers; production of waste absorbents,  Vol. 68 (1997b) Inadequate Sufﬁcient
fertilizers, and pesticides
Refractory ceramic ﬁbers Production; furnace insulators; ship builders; heat- Vol. 81 (2002a) Inadequate Sufﬁcient
resistant fabric manufacture
Rock wool Production; thermal or acoustical insulation Vol. 81 (2002a) Inadequate Limited
Slag wool ﬁreprooﬁng Production; thermal or acoustical insulation Vol. 81 (2002a) Inadequate Limited
Special-purpose glass ﬁbers  Reinforced plastic industry Vol. 81 (2002a) Not available Sufﬁcient
such as E-glass and “475” glass ﬁbers
Metals and metal compounds
Antimony trioxide Ore processing; glass and ceramic production Vol. 47 (1989c) Inadequate Sufﬁcient
Cobalt and cobalt compounds Miners; processing of copper and nickel ore; glass  Vol. 52 (1991a) Inadequate Sufﬁcient
and ceramic production
Lead and inorganic lead compounds Lead smelters; plumbers; solderers; occupations Suppl. 7 (1987) Inadequate  Sufﬁcient
in battery recycling smelters
Methyl mercury compounds Pesticide and fungicide production; paint industry  Vol. 58 (1993a) Inadequate Sufﬁcient
Nickel: metallic and alloys Nickel miners; metal fabrication, grinding,  Vol. 49 (1990a) Inadequate Sufﬁcient
electroplating, and welding
Wood and fossil fuels and their by-products
Benzofuran Production; intermediate in coumarone-indene  Vol. 63 (1995a) Not available Sufﬁcient
resin polymerization; coke production; 
coal gasiﬁcation and combustion
Bitumens, extracts of steam-reﬁned  Production/reﬁning; road construction; rooﬁng and  Suppl. 7 (1987) Inadequate Sufﬁcient
and air-reﬁned ﬂooring
Carbon black Production; paint, ink, plastic and rubber industries Vol. 65 (1996) Inadequate Sufﬁcient
Diesel fuel, marine Petroleum reﬁneries; marine fuel; distribution Vol. 45 (1989b) Inadequate Limited
Fuel oils, residual (heavy) Petroleum reﬁneries; distribution; marine ﬂeets; most  Vol. 45 (1989b) Inadequate Sufﬁcient
large diesel engines operated on land; industrial 
heating systems
Gasoline Petroleum reﬁneries; transportation; mechanics and  Vol. 45 (1989b) Inadequate Limited
service station attendants
Gasoline engine exhaust Transportation and vehicle maintenance workers;  Vol. 46 (1989a) Inadequate Limited
drivers; toll attendants; trafﬁc controllers
Naphthalene Production; insecticide, resin, and pharmaceutical  Vol. 82 (2002b) Inadequate Sufﬁcient
production
Polyaromatic hydrocarbons
Benzo[b]ﬂuoranthene Work involving combustion of organic matter Vol. 32 (1983b) Not available Sufﬁcient
Benzo[j]ﬂuoranthene Work involving combustion of organic matter Vol. 32 (1983b) Not available Sufﬁcient
Benzo[k]ﬂuoranthene Work involving combustion of organic matter Vol. 32 (1983b) Not available Sufﬁcient
Dibenz[a,h]acridine Production; used in dye synthesis; biochemical  Vol. 32 (1983b) Not available Sufﬁcient
laboratory workers; work involving combustion 
of organic matter
Dibenz[a,j]acridine Production; dye synthesis; work involving combustion  Vol. 32 (1983b) Not available Sufﬁcient
of organic matter
Dibenzo[a,e]pyrene Production; biochemical laboratory workers; work  Vol. 32 (1983b) Not available Sufﬁcient
involving combustion of organic matter
Dibenzo[a,h]pyrene Production; biochemical laboratory workers; work  Vol. 32 (1983b) Not available Sufﬁcient
involving combustion of organic matter
Dibenzo[a,i]pyrene Work involving combustion of organic matter Vol. 32 (1983b) Not available Sufﬁcient
Dibenzo[a,l]pyrene Production; biochemical laboratory workers; work  Vol. 32 (1983b) Not available Sufﬁcient
involving combustion of organic matter
Monomers
Acrylonitrile Production; acrylic textile ﬁber and plastic production Vol. 71 (1999a) Inadequate Sufﬁcient
Chloroprene Production; manufacture of polychloroprene  Vol. 71 (1999a) Inadequate Sufﬁcient
(synthetic rubber)
Ethyl acrylate Production; plastic molding occupations using  Vol. 39 (1986a) Not available Sufﬁcient
acrylate resins
Isoprene Production; synthetic rubber and plastics industries  Vol. 71 (1999a) Not available Sufﬁcient
Styrene Polyester resin manufacture; production of  Vol. 82 (2002b) Limited Limited
packaging materials and ﬁberglass-reinforced polyester
Toluene diisocyanates Production; production of polyurethane foams and wire  Vol. 71 (1999a) Inadequate Sufﬁcient
coating; insulation workers; ship builders
Urethane Production; amino-resin production Vol. 7 (1974a) Not available Sufﬁcient
Vinyl acetate Production; plastics, paint, and adhesive industries  Vol. 63 (1995a) Not available Limited
Intermediates in plastics and rubber manufacturing
Acetaldehyde Acetic acid production workers; dyestuff, plastic and  Vol. 71 (1999a) Inadequate Sufﬁcient
synthetic rubber industries
Acetamide Production; plastics and chemical industries Vol. 71 (1999a) Not available Sufﬁcient
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2,4-Diaminotoluene Production; chemical intermediate in TDI production;  Vol. 16 (1978) Not available Sufﬁcient
dyes for textiles; leather; furs; wood; biologic stain;
photo developer
1,2-Epoxybutane Production; metal degreasing; plastics industry  Vol. 71 (1999a) Not available Limited
Ethylbenzene Production; ink, paint, and plastic production Vol. 77 (2000b) Inadequate Sufﬁcient
Ethylene thiourea Production; vulcanization in the rubber industry;  Vol. 79 (2001b) Inadequate Sufﬁcient
manufacture of ethylenebisdithiocarbamate pesticides;
electroplating baths; dyes; pharmaceuticals; 
synthetic resins
Phenyl glycidyl ether Production; epoxy resins; casting and molding  Vol. 71 (1999a) Not available Sufﬁcient
Propylene oxide Production; polyurethane foam and glycol production,  Vol. 60 (1994) Inadequate Sufﬁcient
fumigant
Chlorinated hydrocarbons
Carbon tetrachloride Production; industrial degreasing occupations; dry  Vol. 71 (1999a) Inadequate Sufﬁcient
cleaners; refrigerant production
Chlorinated parafﬁn of average  Production; polyvinyl chloride processing industry  Vol. 48 (1990b) Not available Sufﬁcient
carbon-chain length C12
Chloroform Refrigerant production; dyes, solvents, and pesticides  Vol. 73 (1999b) Inadequate Sufﬁcient
1,2-Dichloroethane Vinyl chloride production workers Vol. 71 (1999a) Inadequate Sufﬁcient
Dichloromethane Production; painters and furniture restorers; Vol. 71 (1999a) Inadequate Sufﬁcient
pharmaceutical and electronic production
Hexachloroethane Production; aluminum reﬁnery; industrial ﬁreﬁghters Vol. 73 (1999b) Inadequate Sufﬁcient
Aromatic amine dyes
Auramine (technical grade) Production; textiles, plastic, and printing Suppl. 7 (1987) Inadequate Sufﬁcient
Benzyl violet 4B Production; food; drugs; cosmetics; textiles Vol. 16 (1978) Not available Sufﬁcient
CI Basic Red 9 Production; textiles; printing; biologic stains (basic  Vol. 57 (1993b) Inadequate Sufﬁcient
fuchsin dye in laboratories)
2,4-Diaminoanisole Dyestuff industry; barbers and cosmetologists; furriers  Vol. 79 (2001b) Not available Sufﬁcient
3,3´-Dimethylbenzidine  Production; dye or intermediate in dye and pigment Vol. 1 (1972) Not available Sufﬁcient
(o-tolidine)  production; polyurethane elastomers; coating; plastics;
clinical laboratories
2,6-Dimethylaniline (2,6-xylidine) Production; dyestuffs and pharmaceutical manufacturing Vol. 57 (1993b) Not available Sufﬁcient
3,3’-Dichlorobenzidine Production; dyestuff manufacturing  Vol. 29 (1982b) Inadequate Sufﬁcient
4,4’-Diaminodiphenyl ether Production; polyamide-type resin manufacturing Vol. 29 (1982b) Not available Sufﬁcient
Disperse Blue 1 Production; hair coloring; textiles and plastics Vol. 48 (1990b) Not available Sufﬁcient
HC Blue No. 1 Production; hair dye Vol. 57 (1993b) Not available Sufﬁcient
4,4´-Methylenedianiline Production; production of diisocyanates, polyisocyanates,  Vol. 39 (1986a) Not available Sufﬁcient
and epoxy resins
Magenta containing  Production; textiles and printing; biologic stains in  Vol. 57 (1993b) Not available Sufﬁcient
CI Basic Red 9 laboratories; photography
Azo dyes
ortho-Aminoazotoluene Production; textiles and leather Vol. 8 (1975) Not available Sufﬁcient
para-Aminoazobenzene Production; textiles and leather Suppl. 7 (1987) Not available Sufﬁcient
CI Acid Red 114 Production; textiles and leather Vol. 57 (1993b) Not available Sufﬁcient
CI Direct Blue 15 Production; textiles and paper Vol. 57 (1993b) Not available Sufﬁcient
Citrus Red No. 2 Production; used for food coloring Vol. 8 (1975) Not available Sufﬁcient
para-Dimethylaminoazobenzene Production; textiles; laboratories Vol. 8 (1975) Not available Sufﬁcient
Oil orange SS Production; dyes/pigments for varnishes, oils, fats,  Vol. 8 (1975) Not available Sufﬁcient
and waxes
Ponceau 3R Production; textiles Vol. 8 (1975) Not available Sufﬁcient
Ponceau MX Production; textiles; leather; inks; paper; wood stains;  Vol. 8 (1975) Not available Sufﬁcient
food; biology laboratories
Trypan blue Production; textiles and printing; biologic stains in life  Vol. 8 (1975) Not available Sufﬁcient
science laboratories; used by ophthalmologists
Intermediates for the manufacture of dyes
para-Cresidine Production; manufacture of dyes, pigments, and perfumes Vol. 27 (1982a) Not available Sufﬁcient
3,3´-Dimethoxybenzidine  Production; manufacture of dyes and pigments; dye for  Suppl. 7 (1987) Inadequate Sufﬁcient
(ortho-dianisidine) leather, paper, plastics, rubber, textiles, and laboratories
2-Methyl-1-nitro anthraquinone  Production; synthesis of anthraquinone dyes Vol. 27 (1982a) Not available Sufﬁcient
(of uncertain purity/impurity)
4,4´-Methylene bis (2-methylaniline) Production; manufacture of dyes and pigments  Suppl. 7 (1987) Inadequate Sufﬁcient
2-Nitroanisole Production; manufacture of the dye intermediates  Vol. 65 (1996) Not available Sufﬁcient
ortho-anisidine and ortho-dianisidine
4,4´-Thiodianiline Production; manufacture of dyes Vol. 27 (1982a) Not available Sufﬁcient
Nitro compounds
2,4-Dinitrotoluene Production; manufacture of diisocyanates and munitions Vol. 65 (1996) Inadequate Sufﬁcient
2,6-Dinitrotoluene Production; manufacture of diisocyanates and munitions Vol. 65 (1996) Inadequate Sufﬁcient
Nitrobenzene Production; manufacture of dyestuffs, detergents, and  Vol. 65 (1996) Not available Sufﬁcient
cosmetics
2-Nitroﬂuorene Underground miners using diesel-powered machinery  Vol. 46 (1989a) Not available Sufﬁcient
Table 5. Continued
IARC Monograph Human Animal
Substance or mixture Occupation or industry in which thesubstance is founda volume (year)b evidencec evidencec
Continued next pageoccupational carcinogens. Only a small frac-
tion of occupational agents have been ade-
quately investigated with epidemiologic data.
There are many reasons for this including,
inter alia, the magnitude of the numbers of
agents to be investigated, a shift away from
occupational cancer research in the epidemio-
logic community and into new areas of epi-
demiologic interest, the difficulty and
challenge of exposure assessment, and increas-
ing barriers to accessing human subjects for
occupational studies. These are problems that
deserve attention, or we will fail in our respon-
sibilities.
Many countries have agencies that list car-
cinogens. In the United States the two pri-
mary sources of information on occupational
carcinogens, at least in the form of lists, are
NIOSH and the NTP. NIOSH publishes a
list of agents that it considers to be occupa-
tional carcinogens (NIOSH 2004). Currently
there are 133 agents on this list. There is no
further information in the NIOSH list regard-
ing the degree of evidence for different agents,
the occupations where these may occur or on
the target organs, or the criteria and methods
used to establish and update this list. The
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2-Nitropropane Production; ink, paint, explosives industries Vol. 71 (1999a) Not available Sufﬁcient
1-Nitropyrene Production; manufacture of azidopyrene; particulate  Vol. 46 (1989a) Not available Sufﬁcient
emissions
4-Nitropyrene Production; used only as a laboratory chemical;  Vol. 46 (1989a) Not available Sufﬁcient
probably present before 1980 in carbon black used 
in photocopy machines
Tetranitromethane Production; diesel fuel additive; TNT manufacturing  Vol. 65 (1996) Not available Sufﬁcient
Pesticides
Aramite Production; in miticides in greenhouses, nurseries,  Vol. 5 (1974b) Not available Sufﬁcient
and orchards
Chlordane Production; termite control  Vol. 79 (2001b) Inadequate Sufﬁcient
Chlordecone Production; insecticide Vol. 20 (1979a) Not available Sufﬁcient
Chlorophenoxy herbicides Production; defoliant Suppl. 7 (1987) Limited Inadequate
Chlorothalonil  Production; fungicide, bactericide, and nematocide Vol. 73 (1999b) Not available Sufﬁcient
DDT (p,p’-DDT) Production; nonsystemic insecticide Vol. 53 (1991b) Inadequate Sufﬁcient
1,2-Dibromo-3-chloropropane Production; pesticide, nematocide, and soil fumigant Vol. 71 (1999a) Inadequate Sufﬁcient
para-Dichlorobenzene  Production; pesticide Vol. 73 (1999b) Inadequate Sufﬁcient
Dichlorvos Production; insecticide and miticide Vol. 53 (1991b) Inadequate Sufﬁcient
Heptachlor Production; termite control  Vol. 79 (2001b) Inadequate Sufﬁcient
Hexachlorobenzene  Production; in chlorinated pesticides and fungicides;  Vol. 79 (2001b) Inadequate Sufﬁcient
dye manufacture and synthesis of organic chemicals 
and rubber; plasticizer for polyvinyl chloride; wood 
preservative; by-product of the production of a 
number of chlorinated solvents
Hexachlorocyclohexanes  Production; woodworkers; farm workers  Suppl. 7 (1987) Inadequate Sufﬁcient
(most common form is Lindane)
Mirex  Production; ﬁre-retardant additive; insecticide; workers  Vol. 20 (1979a) Not available Sufﬁcient
at hazardous waste sites
Nitrofen Production; herbicide Vol. 30 (1983a) Not available Sufﬁcient
Sodium ortho-phenylphenate Production; fungicide; chemical intermediate Vol. 73 (1999b) Not available Sufﬁcient
Toxaphene (polychloronated camphenes) Production; insecticide Vol. 79 (2001b) Inadequate Sufﬁcient
Others
Butylated hydroxyanisole (BHA) Production; food and pharmaceutical industries  Vol. 40 (1986b) Not available Sufﬁcient
Catechol  Production; insecticide and pharmaceutical production;  Vol. 71 (1999a) Not available Sufﬁcient
tanneries
Diglycidyl resorcinol ether Production; liquid spray epoxy resin in electrical,  Vol. 71 (1999a) Not available Sufﬁcient
tooling, adhesive, and laminating applications; 
production of epoxy resins and rubber; aerospace industry
1,4-Dioxane Production; chlorinated solvents; textile processing;  Vol. 71 (1999a) Inadequate Sufﬁcient
mixed with pesticides
Hydrazine Production; manufacture of agricultural chemicals  Vol. 71 (1999a) Inadequate Sufﬁcient
and chemical blowing agents; water treatment; spandex 
ﬁbers; rocket fuel; oxygen scavenger in water boilers 
and heating systems; scavenger for gases; plating 
metals on glass and plastics; solder ﬂuxes; photographic 
developers; reactant in fuel cells in the military; 
reducing agent in electrode-less nickel plating;
chain extender in urethane; textile dyes; explosives
Nitrilotriacetic acid and its salts Production; textiles; electroplaters; tanners  Vol. 73 (1999b) Not available Sufﬁcient
Polychlorophenols and their sodium Herbicide production; wood, textile and leather Vol. 71 (1999a) Limited Inadequate
salts (mixed exposure) manufacturing
Potassium bromate Production; bakeries Vol. 73 (1999b) Not available Sufﬁcient
Thiourea Production; photoprocessing; dyes; rubber industry  Vol. 79 (2001b) Not available Sufﬁcient
Welding fumes Metal fabricating industry  Vol. 49 (1990a) Limited Inadequate
TDI, toluene diisocyanate.
aNot necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term “production” is used to
indicate that this substance is man-made and that workers may be exposed in the production process. bMost recent IARC evaluation; for those referenced as Supplement 7 (IARC 1987),
it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated at an earlier date. cAs judged by the IARC working group; we added the notation
“not available” to signify those substances for which there was no epidemiologic evidence at all.
Table 5. Continued
IARC Monograph Human Animal
Substance or mixture Occupation or industry in which the substance is founda volume (year)b evidencec evidencecNTP has been mandated under the Public
Health Service Act (1978) to maintain a list
of human carcinogens and to provide data on
each one concerning exposure circumstances
and regulatory policies (NTP 2002). This list
uses a two-category scale: “known to be a
human carcinogen” and “reasonably antici-
pated to be a human carcinogen.” Currently,
there are 52 agents listed in the ﬁrst category
and 176 in the second. Information concern-
ing each agent is described in a brief report
that includes some exposure data as well as
health effects data and regulatory data (NTP
2002). The substances on these lists are not
limited to occupational agents, and there is
no tabular summary of occupational agents,
the occupations in which these may occur, or
the target organs. It is beyond the scope of
this article to carry out a comparison of the
procedures and lists of the various national
bodies. Suffice it to say that most of them
draw heavily on the IARC program and adapt
it to their purposes.
There is sometimes a tendency to inter-
pret tables of carcinogens in too categorical a
fashion. Although it may be convenient for
lobbyists and regulators to divide the world of
chemicals and occupational circumstances into
“good guys” and “bad guys,” such a dichotomy
is simplistic. The determination that a sub-
stance or circumstance is carcinogenic depends
on the strength of evidence at a given point in
time. The evidence is sometimes clear-cut
(which would correspond to evaluations of
group 1 or group 4), but more often it is not.
The balance of evidence can change in either
direction as new data emerge.
The characterization of an occupation or
industry group as a “high-risk group” is
strongly rooted in time and place. For
instance, the fact that some groups of nickel
refinery workers experienced excess risks of
nasal cancer does not imply that all workers
in all nickel reﬁneries will be subject to such
risks. The particular circumstances of the
industrial process, raw materials, impurities,
and control measures may produce risk in
one nickel refinery but not in another or in
one historic era but not in another. The same
can be said of rubber production facilities,
aluminum refineries, and other industries
and occupations. Labeling a chemical sub-
stance as a carcinogen in humans is a more
timeless statement than labeling an occupa-
tion or industry as a high-risk group.
However, even such a statement requires
qualification. Different carcinogens produce
different levels of risk, and for a given car-
cinogen there may be vast differences in the
risks incurred by different people exposed
under different circumstances. Indeed, there
may be threshold effects or interactions with
other factors, environmental or genetic, that
produce no risk for some exposed workers and
high risk for others.
This raises the issue of quantitative risk
assessment, which is an important tool in pre-
vention of occupational cancer. Unfortunately,
our tables provide no basis for gauging the
strength of the effect of each carcinogen, either
in relative risk terms or in absolute risk terms,
or in terms of dose–response relationships. The
IARC evaluations provide no such indications,
and although it would be most desirable to
have such information, for most agents the
information base to support such quantiﬁca-
tion is fragmentary. 
In summary, the listing of occupational
carcinogens is important. It provides a yard-
stick of our knowledge base, it provides guid-
ance in setting research priorities, and it
provides an important tool for prevention of
cancer. Regulatory procedures and other
aspects of cancer prevention depend on the
listing of carcinogens. The IARC Monograph
Program has been an indispensable compo-
nent of this process. The tables presented
herein, based on IARC Monographs but aug-
mented in various ways, will be useful to
researchers in setting research priorities and in
furthering our understanding of carcinogene-
sis, and to those interested in preventing
occupational cancer.
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Table 6. Occupations or industries that have been evaluated by IARC as deﬁnitely (group 1), probably (group 2A), or possibly (group 2B) entailing excess risk of
cancer among workers.
IARC Monograph
Occupation or industry Suspected substance volume (year)a Group Site(s)
Aluminum production Pitch volatiles; aromatic amines Suppl. 7 (1987) 1 Lung,b bladderb
Auramine manufacture 2-Naphthylamine; auramine; other chemicals;  Suppl. 7 (1987) 1 Bladderb
pigments
Boot and shoe manufacture and repair  Leather dust; benzene and other solvents Suppl. 7 (1987) 1 Leukemia,b nose,b paranasal 
sinuses,b bladderc
Carpentry and joinery Wood dust Suppl. 7 (1987) 2B
Coal gasiﬁcation Coal tar; coal-tar fumes; PAHs Vol. 34 (1984) 1 Skin (including scrotum),b
bladder,b lungb
Coke production Coal-tar fumes Suppl. 7 (1987) 1 Skin (scrotum),b lung,b bladder,c
kidneyc
Dry cleaning Solvents and chemicals used in “spotting” Vol. 63 (1995a) 2B
Furniture and cabinet making Wood dust Suppl. 7 (1987) 1 Nose and sinonasal cavitiesb
Hairdressers and barbers Dyes (aromatic amines, amino-phenols with  Vol. 57 (1993b) 2A Bladder,c lung,c non-Hodgkin 
hydrogen peroxide); solvents; propellants;  lymphoma,c ovaryc
aerosols
Hematite mining, underground, with  Radon daughters; silica Suppl. 7 (1987) 1 Lungb
radon exposure
Iron and steel founding PAHs; silica; metal fumes; formaldehyde Suppl. 7 (1987) 1 Lungb
Isopropanol manufacture, strong-acid process  Diisopropyl sulfate; isopropyl oils; sulfuric acid Suppl. 7 (1987) 1 Paranasal sinuses,b larynx,b lungc
Magenta manufacture Magenta; ortho-toluidine; 4,4´-methylene  Vol. 57 (1993b) 1 Bladderb
bis(2-methylaniline); ortho-nitrotoluene
Painters Vol. 47 (1989c) 1 Lung,b bladder,c stomachc
Petroleum reﬁning PAHs Vol. 45 (1989b) 2A Bladder,c brain,c leukemiac
Printing processes Solvents; inks Vol. 65 (1996) 2B
Production of art glass, glass containers,  Lead; arsenic; antimony oxides; silica; asbestos;  Vol. 58 (1993a) 2A Lungc
and pressed ware other metal oxides; PAHs
Rubber industry Aromatic amines; solvents  Suppl. 7 (1987) 1 Bladder,b stomach,c larynx,c
leukemia,c lungc
Textile manufacturing industry Textile dust in manufacturing process; dyes  Vol. 48 (1990b) 2B
and solvents in dyeing and printing operations
aMost recent IARC evaluation; for those referenced as Supplement 7 (IARC 1987), it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated
at an earlier date. bWe judged that the evidence for an association with this site was strong. cWe judged that the evidence was suggestive.Review | Siemiatycki et al.
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Table 8. Evolution in knowledge regarding current
(2003) IARC occupational carcinogens.
Earlier evaluation
Current rating Past rating IARC 1987 WHO 1964
1 (n = 28)  1 19 13
2A 4   4
2B 1
30 N A
Unrated 4 11
Total 28 28
2A (n = 27)  1 0 0
2A 16   0
2B 6
32 N A
Unrated 3 27
Total 27 27
2B (n = 113)  1 0 1
2A 2  5
2B 63
39 N A
Unrated 39 107
Total 113 113
NA, not applicable.